Abstract
Atopic dermatitis (AD), characterized by skin barrier dysfunction and inflammation, is associated with food allergy and asthma development. Underlying mechanisms for disease co-expression remain poorly understood. The skin microbiome’s role in modulating skin disorders, including AD, and systemic immunity is still under investigation. We hypothesize that metabolic output of skin-associated bacteria in AD contributes to barrier dysfunction and the atopic march.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
